Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

1.40
Delayed Data
As of 3:59pm ET
 +0.01 / +0.72%
Today’s Change
1.17
Today|||52-Week Range
3.49
-45.10%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close1.39
Today’s open1.39
Day’s range1.38 - 1.42
Volume155,237
Average volume (3 months)502,551
Market cap$59.2M
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)+10.58%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book0.43

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...-0.05-2.62%
ATXIAvenue Therapeutics ...-0.37-6.79%
XENEXenon Pharmaceutical...+0.02+0.86%
APDNApplied DNA Sciences...+0.08+3.20%
Data as of 4:00pm ET, 09/25/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts